4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-267605
Options or other derivatives
- Director acquired 73,318 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-09 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +70,000 | 70,000 | D |
| 2026-06-09 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +3,318 | 3,318 | D |
Loading xslF345X06/ownership.xml…